ClearNote Health Secures $52 Million in Series D Financing, led by Mattias Westman, to enhance early cancer detection efforts.
Amount Raised
$52 Million
Round Type
Series D
Investors
Description
ClearNote Health has announced the close of $52 million in Series D financing to bolster its efforts in early cancer detection. The financing will aid in commercial expansion, clinical study execution, and product development. This round was led by investor Mattias Westman, along with contributions from several institutional investors. CEO Dave Mullarkey expresses confidence in the company's growth trajectory and market opportunity.
Who else raised in Medical Device and Health Diagnostics around the same time
Companies in the same sectors as ClearNote Health that raised within 45 days of this round, from Fundz verified event records.
- Respiro Diagnostics raised $1.3M (Pre-Seed) on July 8, 2026.
- Imagion Biosystems raised $2.8M (Post-IPO Equity) on June 25, 2026.
- Grail raised $110M (Post-IPO Equity) on June 25, 2026.
- Uncovr raised $7M (Seed) on June 10, 2026.
- Captive Radiology raised an undisclosed amount on May 27, 2026.
- Neurosoft Bioelectronics raised $7.5M (Seed) on May 20, 2026.
Who to call at ClearNote Health, and when
A new round usually means ClearNote Health is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day ClearNote Health raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at ClearNote Health, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at ClearNote Health. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment ClearNote Health raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
ClearNote Health raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.